Anandamide Suppresses Proliferation and Cytokine Release from Primary Human T-Lymphocytes Mainly via CB2 Receptors
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Anandamide (AEA) is an endogenous lipid mediator that exerts several effects in the brain as well as in peripheral tissues. These effects are mediated mainly by two types of cannabinoid receptors, named CB(1)R and CB(2)R, making AEA a prominent member of the "endocannabinoid" family. Also immune cells express CB(1) and CB(2) receptors, and possess the whole machinery responsible for endocannabinoid metabolism. Not surprisingly, evidence has been accumulated showing manifold roles of endocannabinoids in the modulation of the immune system. However, details of such a modulation have not yet been disclosed in primary human T-cells. METHODOLOGY/SIGNIFICANCE: In this investigation we used flow cytometry and ELISA tests, in order to show that AEA suppresses proliferation and release of cytokines like IL-2, TNF-alpha and INF-gamma from activated human peripheral T-lymphocytes. However, AEA did not exert any cytotoxic effect on T-cells. The immunosuppression induced by AEA was mainly dependent on CB(2)R, since it could be mimicked by the CB(2)R selective agonist JWH-015, and could be blocked by the specific CB(2)R antagonist SR144528. Instead the selective CB(1)R agonist ACEA, or the selective CB(1)R antagonist SR141716, were ineffective. Furthermore, we demonstrated an unprecedented immunosuppressive effect of AEA on IL-17 production, a typical cytokine that is released from the unique CD4+ T-cell subset T-helper 17. CONCLUSIONS/SIGNIFICANCE: Overall, our study investigates for the first time the effects of the endocannabinoid AEA on primary human T-lymphocytes, demonstrating that it is a powerful modulator of immune cell functions. In particular, not only we clarify that CB(2)R mediates the immunosuppressive activity of AEA, but we are the first to describe such an immunosuppressive effect on the newly identified Th-17 cells. These findings might be of crucial importance for the rational design of new endocannabinoid-based immunotherapeutic approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Surface expression of CB1R and CB2R on primary human T-lymphocytes. Freshly isolated human T-lymphocytes were stimulated or not with anti-CD3 and anti-CD28 for 24 hours. Panels A–B: Surface expression of CB1R and CB2R was reported as MIF (medium intensity of fluorescence) values on a FACS-Canto, gating for CD4+CD3+ and CD4−CD3+ cells (A), and by confocal microscopy staining with anti-CD3, and anti-CB1R or anti-CB2R (B). Panel C: Resting or activated T-cells were either left untreated or incubated with 2.5 µM CP55.940 (CP), 20 µg/ml saponin, 25 µM GDP and 0.3 nM [35S]GTPγS. The amount of [35S]GTPγS bound is reported as counts per min (cpm) per 2.5×106 cells. * Indicates p<0.005 versus CD3/CD28-treated cells. Data are representative of 4 independent experiments.](https://figures.cochat.ai/paper-figures/1b32650b5f4d4227b93e359413987415/anandamide-suppresses-proliferation-and-cytokine-release-from-primary-human-t-figure-2.jpg)

![Figure 4 Effect of AEA on IL-2 dependent anti-CD3/anti-CD28-stimulated T-cell proliferation. Purified resting or CD3/CD28-activated T-lymphocytes (1×105 cells/well) were either left untreated or treated with 2.5 µM AEA and/or cannabinoid receptors agonists or antagonists (each at 1.0 µM). Panel A: Treated or untreated cells were incubated overnight with [3H]-thymidine. Levels of [3H]-thymidine incorporation were measured as reported in Materials and Methods. Data were reported as the mean ± SD of 8 independent experiments. * Indicates p<0.001 versus CTRL cells, # p<0.01 versus CD3/CD28-treated cells, § p<0.001 versus CD3/CD28+AEA-treated cells, and Δ p<0.01 versus CD3/CD28+JWH-015-treated cells. Panel B: Supernatants of treated or untreated cells cultured for 24 hours were collected, and IL-2 levels were quantified by means of ELISA. Data are reported as the mean (± SD) of 6 independent experiments. * Indicates p<0.001 versus CTRL cells, # p<0.01 versus CD3/CD28-treated cells, § p<0.05 versus CD3/CD28+AEA-treated cells, §§ p<0.001 versus CD3/CD28+AEA-treated cells, and Δ p<0.01 versus CD3/CD28+JWH-015-treated cells.](https://figures.cochat.ai/paper-figures/793e7c23cf2b42bfb12b96d68c263875/anandamide-suppresses-proliferation-and-cytokine-release-from-primary-human-t-figure-4.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In addition it inhibits T cell proliferation and production of TNF-α and IFN-γ by CD4+ and CD8+ T cells and IL-17 by Th17 cells [108].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [108]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Pharmacology of cannabinoid CB1 and CB2 receptors
Pertwee, R. G. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(97)82001-3 · Cited by 1,470 · cited 1×
“These receptors are differentially distributed among cells, with CB1R being preferentially expressed in the brain and in other neural tissues, whilst CB2R is found mainly in cells of the immune system [4,5].”
BackgroundThe cannabinoid system and immune modulation
Klein, T. W., Newton, C., Larsen, K., Lu, L., Perkins, I., Nong, L., & Friedman, H. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0303101 · Cited by 524 · cited 1×
“regulating and fine-tuning several processes, including neuroprotection [6] and immune responses [7].”
BackgroundThe roles of IL‐17A in inflammatory immune responses and host defense against pathogens
Iwakura, Y., Nakae, S., Saijo, S., & Ishigame, H. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00699.x · Cited by 513 · cited 1×
“In the present study we sought to better define the role of AEA in modulating immune functions of primary human T cells, with a special focus on the key regulators of autoimmune inflammation: Th17 lymphocytes [17].”
BackgroundBiochemistry and pharmacology of endovanilloids
Starowicz, K., Nigam, S., & Di Marzo, V. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.01.005 · Cited by 383 · cited 5×
“Incidentally, it should be recalled that AEA is also an endogenous agonist of type-1 vanilloid receptors (TRPV1) [19].”
BackgroundInfluentialHillard, C. J., Manna, S., Greenberg, M. J., DiCamelli, R., Ross, R. A., Stevenson, L. A., Murphy, V., Pertwee, R. G., & Campbell, W. B. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38289-8 · Cited by 374 · cited 1×
“In addition, there are reports that even AEA might not act as a physiological agonist of CB2R [25], although this endocannabinoid has been shown to exert manifold CB2R-dependent activities in experimental paradigms, and more recently its localization within biological membranes has led to a reconsideration of its role…”
BackgroundMaresz, K., Pryce, G., Ponomarev, E. D., Marsicano, G., Croxford, J. L., Shriver, L. P., Ledent, C., Cheng, X., Carrier, E. J., Mann, M. K., et al. (2007) · Nature Medicine · doi:10.1038/nm1561 · Cited by 363 · cited 1×
“Using animal models of MS like experimental autoimmune encephalomylelitis (EAE), CB1R and CB2R have been shown to be specific markers of MS plaque cell subtypes [21]; furthermore, CB1R has been proven to mediate suppression of CNS autoimmune inflammation on neurons, whilst CB2R had the same anti-inflammatory role on a…”
MethodAnandamide Induces Apoptosis in Human Cells via Vanilloid Receptors
Maccarrone, M., Lorenzon, T., Bari, M., Melino, G., & Finazzi-Agrò, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005722200 · Cited by 347 · cited 1×
“In addition, AEA decreases mitogeninduced T and B cell proliferation [13], suppresses CD8 T lymphocyte migration [14], and induces apoptosis in macrophages [15] and dendritic cells [16].”
BackgroundSelf-citationFelder, C. C., Nielsen, A., Briley, E. M., Palkovits, M., Priller, J., Axelrod, J., Nguyen, D. N., Richardson, J. M., Riggin, R. M., Koppel, G. A., et al. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00891-5 · Cited by 326 · cited 1×
“cells, macrophages, microglia, and lymphocytes [9].”
Production of nitric oxide by glial cells: Regulation and potential roles in the CNS
Murphy, S. (2000) · Glia · doi:10.1002/(sici)1098-1136(20000101)29:1<1::aid-glia1>3.0.co;2-n · Cited by 314
Endocannabinoids: synthesis and degradation
Di Marzo, V. (2006) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/112_0505 · Cited by 311 · cited 1×
“mediators isolated from brain and peripheral tissues [1,2].”
BackgroundBenito, C., Romero, J. P., Tolón, R. M., Clemente, D., Docagne, F., Hillard, C. J., Guaza, C., & Romero, J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4814-06.2007 · Cited by 256 · cited 1×
“Using animal models of MS like experimental autoimmune encephalomylelitis (EAE), CB1R and CB2R have been shown to be specific markers of MS plaque cell subtypes [21]; furthermore, CB1R has been proven to mediate suppression of CNS autoimmune inflammation on neurons, whilst CB2R had the same anti-inflammatory role on a…”
MethodCannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells
Puffenbarger, R. A., Boothe, A. C., & Cabral, G. A. (2000) · Glia · doi:10.1002/(sici)1098-1136(20000101)29:1<58::aid-glia6>3.0.co;2-w · Cited by 248 · cited 1×
“For instance, AEA suppresses LPS-induced nitric oxide production by mouse peritoneal macrophages [11], and LPS-induced cytokine mRNA expression in rat microglial cells [12].”
BackgroundTh17 cytokines and their emerging roles in inflammation and autoimmunity
Fouser, L. A., Wright, J. F., Dunussi‐Joannopoulos, K., & Collins, M. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00712.x · Cited by 246 · cited 1×
“These cells produce IL-17, a potent cytokine which contributes to host defense against extracellular pathogens and which has been clearly shown to be involved in the development of autoimmune diseases [30].”
BackgroundDo, Y., McKallip, R. J., Nagarkatti, M., & Nagarkatti, P. S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.4.2373 · Cited by 195 · cited 1×
“In addition, AEA decreases mitogeninduced T and B cell proliferation [13], suppresses CD8 T lymphocyte migration [14], and induces apoptosis in macrophages [15] and dendritic cells [16].”
BackgroundSchwarz, H., Blanco, F. J., & Lotz, M. (1994) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)90152-x · Cited by 180 · cited 1×
“. In addition, AEA decreases mitogen-induced T and B cell proliferation”
BackgroundMaccarrone, M., De Petrocellis, L., Bari, M., Fezza, F., Salvati, S., Di Marzo, V., & Finazzi-Agrò, A. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2500 · Cited by 162
Self-citationCB1 and CB2 receptor-mediated signalling: a focus on endocannabinoids
McAllister, S. D., & Glass, M. (2002) · Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) · doi:10.1054/plef.2001.0344 · Cited by 159 · cited 14×
“In addition, it has been shown that chronic marijuana smoking increases CB1R and CB2R mRNA in peripheral blood mononuclear cells [8].”
BackgroundInfluentialAnandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes
Joseph, J., Niggemann, B., Zaenker, K. S., & Entschladen, F. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0509-9 · Cited by 145 · cited 1×
“In addition, AEA decreases mitogeninduced T and B cell proliferation [13], suppresses CD8 T lymphocyte migration [14], and induces apoptosis in macrophages [15] and dendritic cells [16].”
BackgroundRecent Advances in the Development of Selective Ligands for the Cannabinoid CB2 Receptor
Huffman, J. W., & Marriott, K. C. (2008) · Current Topics in Medicinal Chemistry · doi:10.2174/156802608783498014 · Cited by 102 · cited 1×
“In particular, JWH-015 is also a partial agonist of CB1R, although with lower affinity than for CB2R [24].”
BackgroundCompartmentalization of endocannabinoids into lipid rafts in a dorsal root ganglion cell line
Rimmerman, N., Hughes, V., Bradshaw, H. B., Pazos, M., Mackie, K., Prieto, A. L., & Walker, J. M. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707561 · Cited by 89 · cited 1×
“In addition, there are reports that even AEA might not act as a physiological agonist of CB2R [25], although this endocannabinoid has been shown to exert manifold CB2R-dependent activities in experimental paradigms, and more recently its localization within biological membranes has led to a reconsideration of its role…”
BackgroundThe Endocannabinoid System in Peripheral Lymphocytes as a Mirror of Neuroinflammatory Diseases
Centonze, D., Battistini, L., & Maccarrone, M. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208785740018 · Cited by 88 · cited 1×
“mediators isolated from brain and peripheral tissues [1,2].”
BackgroundSelf-citationBari, M., Spagnuolo, P., Fezza, F., Oddi, S., Pasquariello, N., Finazzi‐Agrò, A., & Maccarrone, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.8.4971 · Cited by 77 · cited 1×
“Nonspecific binding was determined in the absence of agonist and in the presence of 10 mM unlabeled GTPcS (Perkin Elmer Life Sciences), as reported [18].”
MethodSelf-citationTetrahydrocannabinol inhibition of macrophage nitric oxide production
Coffey, R. G., Yamamoto, Y., Snella, E. M., & Pross, S. H. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00356-5 · Cited by 77 · cited 1×
“For instance, AEA suppresses LPS-induced nitric oxide production by mouse peritoneal macrophages [11], and LPS-induced cytokine mRNA expression in rat microglial cells [12].”
BackgroundNong, L., Newton, C. A., Cheng, Q., Friedman, H. P., Roth, M. D., & Klein, T. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00113-3 · Cited by 61 · cited 3×
“Jurkat T-cells, mouse macrophages and microglia, as well as human tonsillar B cells and dendritic cells [8].”
BackgroundResultInfluentialCorrea, F., Docagne, F., Clemente, D., Mestre, L., Becker, C., & Guaza, C. (2008) · Biochemical Journal · doi:10.1042/bj20071329 · Cited by 47 · cited 1×
“At any rate, it should be stressed that there are several studies documenting alterations in cytokines release induced by endocannabinoids on immune cells [28,29], but none of them has ever been performed on primary human Tlymphocytes.”
BackgroundRockwell, C. E., Raman, P., Kaplan, B. L. F., & Kaminski, N. E. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.05.005 · Cited by 42 · cited 1×
“At any rate, it should be stressed that there are several studies documenting alterations in cytokines release induced by endocannabinoids on immune cells [28,29], but none of them has ever been performed on primary human Tlymphocytes.”
BackgroundTakano, F., Yamaguchi, M., Takada, S., Shoda, S., Yahagi, N., Takahashi, T., & Ohta, T. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.01.031 · Cited by 40 · cited 1×
“Both capsaicin and capsazepine were used at doses previously shown to be effective on the target receptor in immune cells [20].”
BackgroundCNS Immune Surveillance and Neuroinflammation: Endocannabinoids Keep Control
Wolf, S., Tauber, S., & Ullrich, O. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208785740090 · Cited by 35 · cited 1×
“regulating and fine-tuning several processes, including neuroprotection [6] and immune responses [7].”
BackgroundIhenetu, K., Molleman, A., Parsons, M. E., & Whelan, C. J. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01379-7 · Cited by 26
Good news for CB1 receptors: endogenous agonists are in the right place
Maccarrone, M. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707566 · Cited by 15 · cited 1×
“In addition, there are reports that even AEA might not act as a physiological agonist of CB2R [25], although this endocannabinoid has been shown to exert manifold CB2R-dependent activities in experimental paradigms, and more recently its localization within biological membranes has led to a reconsideration of its role…”
BackgroundSelf-citation
Cited by
Transition from inflammation to proliferation: a critical step during wound healing
Landén, N. X., Li, D., & Ståhle, M. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2268-0 · Cited by 1,980
Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance
Calder, P. C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.08.010 · Cited by 1,717
“AEA and 2-AG act via the CB1 and CB2 receptors [47], and anti-inflammatory properties have been reported for both [48,49].”
BackgroundOmega‐3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?
Calder, P. C. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04374.x · Cited by 1,347
Endocannabinoid signaling at the periphery: 50 years after THC
Maccarrone, M., Bab, I., Bíró, T., Cabral, G. A., Dey, S. K., Di Marzo, V., Konje, J. C., Kunos, G., Mechoulam, R., Pacher, P., et al. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.02.008 · Cited by 646
“In keeping with these findings, Maria Teresa Cencioni and colleagues [78] showed that AEA suppresses release of cytokines like IL-2, tumor necrosis-α and interferon-γ from activated human peripheral T-lymphocytes, mainly through a CB2-dependent mechanism.”
Self-citationThe CB2 receptor and its role as a regulator of inflammation
Turcotte, C., Blanchet, M.-R., Laviolette, M., & Flamand, N. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2300-4 · Cited by 588
Metadata
- Authors
- Cencioni, M. T., Chiurchiù, V., Catanzaro, G., Borsellino, G., Bernardi, G., Battistini, L., & Maccarrone, M.
- Affiliations
- Fondazione Santa Lucia (IT)
- University of Teramo (IT)
- University of Rome Tor Vergata (IT)
- Corresponding author
- Battistini, Luca
- Maccarrone, Mauro
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-01-14
- Volume
- 5
- Issue
- 1
- Pages
- e8688
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2809084
- OpenAlex
- W1991262879
- Cited by
- 235
- References
- 29
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 19 · 2023: 9 · 2022: 15 · 2021: 11 · 2020: 14 · 2019: 13 · 2018: 7 · 2017: 10 · 2016: 18 · 2015: 20 · 2014: 20 · 2013: 22 · 2012: 21
- FWCI
- 14.33
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi dell Aquila (submittedVersion)
- Funders
- Ministero della Salute
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Keywords
- anandamide, endocannabinoids, CB2 receptor, CB1 receptor, T cells, immunosuppression, T cell proliferation, cytokine production, IL-17, Th17 cells, JWH-015, SR144528, SR141716, ACEA
- MeSH terms
- Rimonabant, Arachidonic Acids, Base Sequence, Camphanes, Enzyme-Linked Immunosorbent Assay, Flow Cytometry, Humans, Piperidines, Pyrazoles, T-Lymphocytes, Cytokines, DNA Primers, Microscopy, Confocal, Reverse Transcriptase Polymerase Chain Reaction, Receptor, Cannabinoid, CB2, Cell Proliferation, Polyunsaturated Alkamides, Endocannabinoids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.